Dan chevallard
WebPreviously, Mr. Chevallard served as the Chief Financial Officer and principal financial officer at Regulus Therapeutics from May 2024 to July 2024. Mr. Mr. Chevallard joined … WebIn addition to the appointments of Ms. Madsen and Drs. Dan Chevallard, formerly Chief Financial Officer, has been promoted to Chief Operating Officer and Chief...
Dan chevallard
Did you know?
WebApr 27, 2024 · And after the drinks were covered, Dan Chevallard, COO and Chief Financial Officer of Viracta, spoke about his journey with Viracta, a precision oncology company targeting virus-associated malignancies such as EBV+ cancers. Not only science was covered, but ideas about how to fundraise too, another incredibly important part of a … WebFeb 24, 2024 · Darcy brings financial expertise and extensive experience in the management of public life science companies to Viracta's Board. Mr. Darcy was previously a co-founder and director of Tocagen Inc....
WebNov 13, 2013 · Regulus Therapeutics (NASDAQ:NASDAQ:RGLS) Q3 2013 Earnings Call November 13, 2013 5:00 PM ETExecutivesAmy Conrad - Director, Investor Relations and Corporate CommunicationsKleanthis... WebSenior Management Dan Chevallard Mr. Chevallard has served as Chief Financial Officer of Viracta since July 2024 and Chief Operating Officer since March 2024. Previously, Mr. …
WebAt Viracta Therapeutics, Dan Chevallard has 21 colleagues including Mark Rothera (CEO), Ivor Royston (Director)… Industry Colleagues. In the Biotechnology industry, Dan … WebAug 1, 2024 · Viracta Therapeutics, Inc. announced that it has appointed Dan Chevallard as Chief Financial Officer and Xiaohu Deng, Ph.D. as Senior Vice President of Product …
WebScribd es red social de lectura y publicación más importante del mundo.
WebHeadquarters 2533 S Coast Hwy 101 Ste 210, Cardiff By The Sea, California, 92007, United States Phone Number (858) 400-8470 Website www.viracta.com Revenue $5.1M Stock Symbol VIRX Industry Education General Education Viracta Therapeutics's Social Media Is this data correct? View contact profiles from Viracta Therapeutics Popular Searches chs hiring processWebNov 8, 2024 · “This expanded credit facility increases our financial strength and provides the company with significant strategic and operational flexibility by securing access to a non-dilutive and immediately available financing option that carries an attractive single-digit cost of capital,” Dan Chevallard, COO and CFO at Viracta Therapeutics, said. description of a dental implantWebNov 5, 2024 · "This expanded credit facility increases our financial strength and provides the Company with significant strategic and operational flexibility by securing access to a non-dilutive and immediately... chsh listen -s /sbin/nologin